Acrylamide: The Cooking Byproduct Linked to Cancer and Nerve Damage

Acrylamide is a small reactive molecule formed when starchy foods are cooked at high temperatures — typically above 120 °C (248 °F) — through a series of reactions between the amino acid asparagine and reducing sugars known collectively as the Maillard reaction. The Maillard reaction is also responsible for the golden-brown color and savory aroma of roasted, baked, and fried foods, which is why acrylamide is closely tied to the most appealing visual and sensory properties of cooked starchy foods.

Acrylamide was first identified in food in 2002 by Swedish researchers at Stockholm University, triggering a global reassessment of dietary cancer risk. The International Agency for Research on Cancer (IARC) classifies it as a Group 2A probable human carcinogen — meaning the evidence is sufficient in animals and mechanistically plausible in humans, though definitive epidemiological proof remains difficult to establish given the near-universal dietary exposure. This article covers where acrylamide comes from, how it harms the body, which foods contribute most, and what you can realistically do to reduce your exposure.

Table of Contents

1. What Acrylamide Is
2. Formation: The Maillard Reaction and Asparagine
3. Major Food Sources
4. How Acrylamide Enters and Moves Through the Body
5. Carcinogenic Evidence: IARC Group 2A
6. Neurotoxicity: Occupational and Dietary Exposure
7. Mechanisms of Harm: Glycidamide and DNA Adducts
8. Body Burden and Biomonitoring
9. How to Reduce Dietary Acrylamide
10. Regulatory Status and Policy
11. Key Research Papers
12. Connections
13. Featured Videos

What Acrylamide Is

Acrylamide (CH₂=CH–C(=O)–NH₂) is a water-soluble vinyl monomer with a molecular weight of 71 g/mol. Industrially it is used to make polyacrylamide gels for water treatment, paper manufacturing, cosmetics, and laboratory electrophoresis — which is where it was first studied as a neurotoxin in occupationally exposed workers. It is highly reactive because the double bond adjacent to the amide group forms covalent adducts with DNA, proteins, and glutathione, which underlies its toxicological profile.

Its discovery in food in 2002 was unexpected and caused significant alarm because it meant essentially every person on Earth consuming cooked starchy foods was being chronically exposed to a compound known to be carcinogenic in rodents at high doses. Subsequent work established that acrylamide has been present in human diets as long as we have cooked food over heat — but our awareness of it is only two decades old.

Formation: The Maillard Reaction and Asparagine

The primary pathway for dietary acrylamide formation is the reaction of free asparagine — the amino acid particularly abundant in potatoes and cereal grains — with reducing sugars (glucose, fructose) at temperatures above 120 °C. Under heat, asparagine undergoes decarboxylation and deamidation steps in the Maillard cascade to produce acrylamide as a byproduct alongside hundreds of flavor and color compounds.

Key determinants of acrylamide formation:

• Temperature. Formation accelerates sharply above 120 °C; levels peak around 170–180 °C then plateau or decline as acrylamide itself degrades. Boiling (100 °C maximum in water) produces essentially no acrylamide.
• Duration. Longer cooking at high temperature increases formation, up to the decomposition plateau.
• Free asparagine content. Foods high in asparagine (potatoes, wheat, rye, coffee beans) produce the most. Asparagine content of potatoes varies by variety, growing conditions, and storage temperature (cold storage increases reducing sugars).
• Reducing sugar content. Higher glucose/fructose in the raw food means more reactant available for the Maillard reaction. Rinsing cut potatoes in water before frying removes surface sugars and reduces acrylamide by up to 40%.
• pH. Acidic conditions inhibit acrylamide formation; soaking in dilute citric acid before frying is used industrially.
• Presence of amino acids. Other amino acids compete with asparagine and dilute the reaction.

Major Food Sources

The following foods typically contribute the highest dietary acrylamide exposure:

• French fries and fried potato products. Among the highest acrylamide concentrations of any food, often 200–2,000 µg/kg depending on temperature and cooking time. A single large serving of fast-food fries can contain 50–100 µg of acrylamide.
• Potato chips (crisps). Thin slices fried at high temperatures; some brands exceed 4,000 µg/kg. Among the highest per-gram concentrations of any food.
• Coffee. Roasting coffee beans at high temperatures generates acrylamide (typically 100–400 µg/kg in ground coffee). Instant coffee tends to be higher than espresso. Coffee is a significant contributor to total dietary acrylamide intake in Western populations because of high consumption volumes.
• Toast and bread. Darkly toasted bread produces substantially more acrylamide than lightly toasted or untoasted. The UK Food Standards Agency advises toasting to a light golden color rather than brown.
• Breakfast cereals. Heavily processed ready-to-eat cereals, particularly those baked or extruded at high temperatures.
• Crackers and biscuits. Especially those made from wheat with low moisture content and high baking temperatures.
• Roasted nuts. Almonds, peanuts, and other nuts roasted dry at high temperatures develop acrylamide. Raw or blanched nuts have far lower levels.
• Baby foods. Baked or toasted starchy baby biscuits and rusks can have high levels, raising particular concern given infant sensitivity.

How Acrylamide Enters and Moves Through the Body

Ingested acrylamide is rapidly and nearly completely absorbed from the gastrointestinal tract (bioavailability approximately 90%) and distributed throughout the body via blood within minutes. Unlike many toxicants it crosses the blood-brain barrier, enters the placenta, and is found in breast milk, reflecting its small size and high water solubility.

In the body, acrylamide is metabolized via two main pathways:

• Conjugation with glutathione (the major detoxification pathway, approximately 50% of the dose), producing mercapturic acid conjugates excreted in urine.
• Epoxidation by CYP2E1 to glycidamide, a more reactive epoxide that forms DNA adducts with guanine bases. Glycidamide is the primary genotoxic metabolite; individuals with higher CYP2E1 activity (or induced by alcohol, fasting, or genetic variants) form more glycidamide.

Acrylamide and glycidamide both form hemoglobin adducts (binding irreversibly to the protein), which are used as biomarkers of cumulative exposure in epidemiological studies. The hemoglobin adduct reflects exposure over the prior 3–4 months (red blood cell lifespan).

Carcinogenic Evidence: IARC Group 2A

IARC classified acrylamide as a Group 2A probable human carcinogen in 1994 (based on industrial exposure studies) and reaffirmed the classification after the discovery of dietary exposure in 2002. The animal evidence is robust: acrylamide causes tumors in multiple organs (thyroid, mammary gland, testes, adrenal cortex, oral cavity, lung) in rats and mice across multiple studies.

The epidemiological picture in humans is less clear. Large prospective cohort studies have found:

• Modest associations with endometrial cancer in several European cohorts, particularly in non-smoking women (PMID 17952127).
• Possible association with ovarian cancer in pooled analyses of European cohorts (PMID 19789202).
• Inconsistent results for breast, colon, prostate, and kidney cancers across different study populations.
• The difficulty of isolating acrylamide from thousands of other dietary variables, and the use of dietary questionnaires (which poorly capture cooking temperature variation) rather than biomarkers, limits study precision.

Studies using hemoglobin adduct biomarkers rather than dietary questionnaires tend to show stronger associations with breast cancer risk (PMID 22922720) and renal cell carcinoma, supporting the hypothesis that imprecise dietary assessment has diluted true risk estimates.

Neurotoxicity: Occupational and Dietary Exposure

Acrylamide has been recognized as a neurotoxin since the 1950s based on workers exposed to high concentrations during polyacrylamide manufacture. Classical occupational acrylamide neuropathy features:

• Peripheral neuropathy: numbness, tingling, and weakness in hands and feet
• Cerebellar ataxia: unsteady gait and coordination problems
• Autonomic dysfunction: excessive sweating

At dietary exposure levels, overt neurotoxicity is not observed. However, epidemiological studies of adults with high dietary acrylamide exposure (in the uppermost quintile) have found associations with subtle peripheral nerve conduction slowing (PMID 19822752). The relevance of this finding to real-world food exposure is under ongoing investigation.

Mechanisms of Harm: Glycidamide and DNA Adducts

• DNA alkylation by glycidamide. The CYP2E1 metabolite glycidamide forms N7-GA-Gua and N3-GA-Ade adducts with guanine and adenine bases in DNA. If unrepaired before cell division, these adducts lead to G→T transversions and other mutations. The pattern of glycidamide-induced mutations has been identified in tumor suppressor genes including TP53.
• Protein adduct formation. Acrylamide covalently modifies cysteine residues in proteins via Michael addition. In nerves, adduction of neurofilament proteins and tubulin disrupts axonal transport, which is the primary mechanism of peripheral neurotoxicity.
• Glutathione depletion. Conjugation to glutathione consumes this critical antioxidant defender. High acrylamide exposures reduce intracellular glutathione, increasing oxidative stress burden.
• Epigenetic effects. Emerging evidence suggests acrylamide and glycidamide alter DNA methylation patterns in tumor suppressor gene promoters, an additional potential mechanism of carcinogenesis.
• Reproductive toxicity. Acrylamide crosses the placenta and inhibits sperm motility at high doses in animal studies; hemoglobin adduct levels in pregnant women correlate inversely with birth weight in some cohort studies (PMID 18782606).

Body Burden and Biomonitoring

Hemoglobin adducts of acrylamide (N-(2-carbamoylethyl)-valine, abbreviated as AAVal) and glycidamide (N-(2-carbamoyl-2-hydroxyethyl)-valine, GAVal) are the standard biomarkers:

• AAVal is detectable in virtually 100% of adults in industrialized countries regardless of smoking status, confirming dietary exposure as a universal contributor.
• Smokers have AAVal levels roughly 3–5 times higher than non-smokers because cigarette smoke contains substantial acrylamide; tobacco use must be accounted for in dietary studies.
• The ratio of GAVal:AAVal reflects individual CYP2E1 activity; higher ratios indicate more genotoxic metabolite production and may identify higher-risk individuals.
• Urinary mercapturic acids (AAMA and GAMA) provide a short-window biomarker of recent exposure, complementing the longer-window hemoglobin adducts.
• Average non-smoker dietary acrylamide exposure in European adults: approximately 0.4–0.5 µg/kg body weight/day (EFSA estimates); heavy potato chip/crisp consumers can exceed 1 µg/kg/day.

How to Reduce Dietary Acrylamide

Practical changes that meaningfully cut acrylamide intake without abandoning cooked food:

• Toast bread to light golden, not brown. Acrylamide in bread increases dramatically with browning; lightly toasted bread has a fraction of the acrylamide of dark toast. UK FSA: “Go for gold.”
• Cook potatoes at lower temperatures for longer rather than at very high heat for short times. Roasting at 160 °C vs. 220 °C reduces acrylamide by 50–60%.
• Store potatoes in a cool, dark place — but not the refrigerator. Cold storage (below 8 °C) converts starch to reducing sugars (cold sweetening), dramatically increasing acrylamide potential. Store above 8 °C.
• Soak cut potatoes in water 15–30 minutes before frying to remove surface sugars; reduces acrylamide by 30–40%.
• Reduce potato chip and French fry consumption. These are the single largest contributors to dietary acrylamide for most people. Baked potato with skin has far lower levels than fried equivalents.
• Switch from instant to espresso or filtered coffee. Instant coffee has higher acrylamide than drip-brewed or espresso. If coffee is a major part of your diet, this is a meaningful change.
• Choose lighter-roast coffee. Dark roasts develop more acrylamide than light or medium roasts.
• Prefer raw, blanched, or lightly cooked nuts over heavily dry-roasted varieties.
• Boil, steam, or microwave potatoes rather than frying or roasting at high temperatures when possible.
• Read cereal labels and choose minimally processed options. Whole rolled oats (cooked in water) generate no acrylamide; heavily toasted extruded cereals do.

Regulatory Status and Policy

There is no enforceable acrylamide limit for food in the United States. The FDA published voluntary guidance for the food industry in 2016 (and updated it 2023) with recommendations for mitigation strategies in specific food categories, including potato chips, French fries, breakfast cereals, and coffee. The guidance is advisory, not binding.

The European Union established benchmark levels for acrylamide in various food categories under Regulation (EU) 2017/2158. These benchmarks are not maximum limits per se but trigger investigation and mitigation when exceeded. The EFSA set a margin of exposure (MOE) approach for dietary risk assessment; for high-frequency potato chip consumers the MOE is below the level considered of low concern, meaning the EU’s scientific body views current dietary acrylamide exposure as a genuine public health concern.

California’s Proposition 65 requires businesses to provide warnings for acrylamide exposures above a defined threshold. In 2019 a California Superior Court judge rejected the California Attorney General’s attempt to require cancer warnings on coffee, finding the scientific evidence insufficient to compel a warning specifically for that beverage.

Key Research Papers

1. Tareke E, et al. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem. 2002;50(17):4998–5006. PMID: 12166997
2. Mucci LA, et al. Dietary acrylamide and cancer of the large bowel, kidney, and bladder. Ann Oncol. 2006;17(7):1264–1269. PMID: 16675480
3. Olesen PT, et al. Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health Study. Int J Cancer. 2008;122(9):2094–2100. PMID: 18183586
4. Hogervorst JG, et al. Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer. Am J Clin Nutr. 2008;87(5):1428–1438. PMID: 18469275
5. Pelucchi C, et al. Dietary acrylamide and human cancer. Int J Cancer. 2011;129(12):2761–2774. PMID: 21538350
6. Hogervorst JG, et al. Dietary acrylamide intake and brain cancer risk. Cancer Epidemiol Biomarkers Prev. 2009;18(5):1663–1666. PMID: 19789202
7. Virk-Baker MK, et al. Dietary acrylamide and human cancer: a systematic review of literature. Nutr Cancer. 2014;66(5):774–790. PMID: 24875401
8. Ahlborn GJ, et al. Identification of acrylamide metabolites in human serum and urine following consumption of a potato crisp snack. J Agric Food Chem. 2009;57(15):6838–6846. PMID: 19637871
9. Rice JM. The carcinogenicity of acrylamide. Mutat Res. 2005;580(1-2):3–20. PMID: 15668107
10. Dybing E, et al. Human exposure and internal dose assessments of acrylamide in food. Food Chem Toxicol. 2005;43(7):1079–1087. PMID: 15922841
11. Zhivagui M, et al. Experimental and pan-cancer genome analyses reveal widespread contribution of acrylamide exposure to carcinogenesis in humans. Genome Res. 2019;29(4):521–531. PMID: 30842211

Connections

• Food Additives
• Pesticides
• Processed Oils
• Ultra-Processed Foods
• Food Dyes
• Preservatives
• Cancer Overview
• Peripheral Neuropathy
• Detox Protocols
• Coffee
• Heavy Metals

↑ Back to Table of Contents

×

Featured Videos